AMCR vs IMDX · P/E 18, rev $23.51B vs rev $271.0K
Amcor PLC (AMCR) versus Insight Molecular Diagnostics Inc. (IMDX) — a side-by-side from cached financials, not a winner call.
Amcor PLC (AMCR) is a packaging & containers company listed on US.
Insight Molecular Diagnostics Inc. (IMDX) is a diagnostics & research company listed on US.
Latest reported AMCR revenue for 2026-06-30 was $23.51B. Net income was $1.11B. Revenue was up 362.5% from 2025-06-30 to 2026-06-30. AMCR currently screens at market cap $22.52B and trailing P/E 17.6.
Latest reported IMDX revenue for 2026-06-30 was $271.0K. Net income was -$15.6M. IMDX currently screens at market cap $0.
AMCR currently screens at market cap $22.52B and trailing P/E 17.6. IMDX currently screens at market cap $0.
Not investment advice. Open the AMCR and IMDX stock pages for the full models.
Not investment advice.